127 related articles for article (PubMed ID: 26535689)
1. Implicating the H63D polymorphism in the HFE gene in increased incidence of solid cancers: a meta-analysis.
Shen LL; Gu DY; Zhao TT; Tang CJ; Xu Y; Chen JF
Genet Mol Res; 2015 Oct; 14(4):13735-45. PubMed ID: 26535689
[TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of the Association between H63D and C282Y Polymorphisms in HFE and Cancer Risk.
Zhang M; Xiong H; Fang L; Lu W; Wu X; Wang YQ; Cai ZM; Wu S
Asian Pac J Cancer Prev; 2015; 16(11):4633-9. PubMed ID: 26107216
[TBL] [Abstract][Full Text] [Related]
3. The association between the C282Y and H63D polymorphisms of HFE gene and the risk of Parkinson's disease: A meta-analysis.
Xia J; Xu H; Jiang H; Xie J
Neurosci Lett; 2015 May; 595():99-103. PubMed ID: 25863172
[TBL] [Abstract][Full Text] [Related]
4. C282Y polymorphism in the HFE gene is associated with risk of breast cancer.
Liu X; Lv C; Luan X; Lv M
Tumour Biol; 2013 Oct; 34(5):2759-64. PubMed ID: 23681799
[TBL] [Abstract][Full Text] [Related]
5. The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.
Lv YF; Chang X; Hua RX; Yan GN; Meng G; Liao XY; Zhang X; Guo QN
J Cell Mol Med; 2016 Jul; 20(7):1219-33. PubMed ID: 26893171
[TBL] [Abstract][Full Text] [Related]
6. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
7. Hemochromatosis gene (HFE) polymorphisms and risk of type 2 diabetes mellitus: a meta-analysis.
Rong Y; Bao W; Rong S; Fang M; Wang D; Yao P; Hu FB; Liu L
Am J Epidemiol; 2012 Sep; 176(6):461-72. PubMed ID: 22908207
[TBL] [Abstract][Full Text] [Related]
8. HFE genetic variability and risk of alcoholic liver disease: A meta-analysis.
Xu YY; Tang YH; Guo XP; Wang J; Yao P
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):626-633. PubMed ID: 27752890
[TBL] [Abstract][Full Text] [Related]
9. Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age.
Shi Z; Johnstone D; Talseth-Palmer BA; Evans TJ; Spigelman AD; Groombridge C; Milward EA; Olynyk JK; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Int J Cancer; 2009 Jul; 125(1):78-83. PubMed ID: 19291797
[TBL] [Abstract][Full Text] [Related]
10. HFE H63D mutation frequency shows an increase in Turkish women with breast cancer.
Gunel-Ozcan A; Alyilmaz-Bekmez S; Guler EN; Guc D
BMC Cancer; 2006 Feb; 6():37. PubMed ID: 16503999
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancer.
Robinson JP; Johnson VL; Rogers PA; Houlston RS; Maher ER; Bishop DT; Evans DG; Thomas HJ; Tomlinson IP; Silver AR
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1460-3. PubMed ID: 15941956
[TBL] [Abstract][Full Text] [Related]
12. Association between HFE polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis of 22 studies including 4,365 cases and 8,652 controls.
Lin M; Zhao L; Fan J; Lian XG; Ye JX; Wu L; Lin H
Mol Biol Rep; 2012 Mar; 39(3):3089-95. PubMed ID: 21701828
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: a meta-analysis of observational studies.
Li M; Wang L; Wang W; Qi XL; Tang ZY
Braz J Med Biol Res; 2014 Feb; 47(3):215-22. PubMed ID: 24604426
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
[TBL] [Abstract][Full Text] [Related]
15. Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis.
Zhang X; He R; Ren F; Tang R; Chen G
J BUON; 2015; 20(3):829-41. PubMed ID: 26214637
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S
Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971
[TBL] [Abstract][Full Text] [Related]
17. Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.
Zhao Q; Zhang B; Chen Y; Li M; Zhao X; Fan H; Li SM
Genet Mol Res; 2015 Dec; 14(4):16921-8. PubMed ID: 26681039
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects.
van der A DL; Rovers MM; Grobbee DE; Marx JJ; Waalen J; Ellervik C; Nordestgaard BG; Olynyk JK; Mills PR; Shepherd J; Grandchamp B; Boer JM; Caruso C; Arca M; Meyer BJ; van der Schouw YT
Circ Cardiovasc Genet; 2008 Oct; 1(1):43-50. PubMed ID: 20031541
[TBL] [Abstract][Full Text] [Related]
19. H63D HFE polymorphisms are associated with increased disease duration and decreased muscle superoxide dismutase-1 expression in amyotrophic lateral sclerosis patients.
Su XW; Lee SY; Mitchell RM; Stephens HE; Simmons Z; Connor JR
Muscle Nerve; 2013 Aug; 48(2):242-6. PubMed ID: 23813494
[TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.
Ellervik C; Birgens H; Tybjaerg-Hansen A; Nordestgaard BG
Hepatology; 2007 Oct; 46(4):1071-80. PubMed ID: 17828789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
